NICE guidelines on breast cancer follow-up need urgent revision

	Tweet

The NICE guidelines on follow-up for breast cancer patients need urgent revision, warn experts in this week’s BMJ.

More than 1.2 million women and men worldwide are diagnosed with breast cancer each year and it is now recognised as a chronic disease that can recur even after 20 -30 years.

Survival continues to improve, so new cancers are now more common in many patients than recurrence because the treatments of the first cancer are so effective. However, follow-up protocols still vary widely both within and between countries and are not always evidence based. 

The National Institute for Health and Clinical Excellence (NICE) in England and Wales state that the aims of breast cancer follow-up are to detect and treat local recurrence, to deal with adverse effects of treatment and to provide psychological support.

The guidelines suggest that these aims can be met by two to three years of follow-up, and that routine long term follow-up is ineffective and unwarranted. They also claim that the yield from mammography is low.

But Michael Dixon, Consultant Surgeon at Edinburgh Breast Unit and David Montgomery, Clinical Research Fellow at Glasgow Royal Infirmary, argue that the NICE guidelines do not meet their stated aims.

Although true local recurrence after breast conserving surgery falls with time, the development of new cancers in the treated breast increases, so the overall rate of ipsilateral breast events is constant at 0.5 to 1% each year for at least the first 10 years and probably for the rest of the patient’s life.

If “recurrences” in the treated breast and armpit are combined together with new cancers in the opposite breast, the annual incidence of treatable disease is constant at 1 to 1.5% for at least the first 10 years, and 70% of such events occur after the first three years.

If NICE is to achieve its aim of detecting and treating local recurrence it clearly cannot be achieved with a three year follow-up, they say.

Data also show that mammography is a very effective way to detect treatable local disease, and fully funded mammographic surveillance programmes specifically for patients with breast cancer are urgently needed, they add.

In contrast to NICE guidelines, they recommend that clinical examination should be annual for two years and surveillance by mammography thereafter.

Ongoing psychological support should also be available, and in between visits for mammograms, patients should have direct access to a named breast care nurse, specialist nurse or doctor and access to prosthesis advice and fitting.

Timely investigation of symptoms and communication of test results is also vital to reduce anxiety and improve ongoing care.

Patients’ needs vary, so follow up programmes for patients with breast cancer patients need to be evidence based, flexible, and tailored to their lifelong needs, they conclude.

Contact: Emma Dickinson

44-020-738-36529
BMJ-British Medical Journal

RELATED STORIES:
MRI cost-effective for some women at high-risk of breast cancer   Red Or White Wine? Both Are Equal in Terms of Breast-Cancer Risk   Breast Cancer Incidence Among Iraqi Women Profiled   Vitamin D and breast cancer risk   Decision guide reduced uncertainty over breast cancer prevention, study finds   Falling breast cancer rates seen only in whites   Broken genomes behind breast cancers   Roche breast cancer pill fails to help older women   Risk of breast cancer mutations underestimated for Asian women, Stanford study shows   ‘Hidden’ Cancer Cells Not a Factor in Early-Stage Breast Cancer Survival Rates   Active Lifestyle Reduces Risk of Invasive Breast Cancer   Novel vaccine shows promise against early-stage breast cancer   Study investigates how age relates to survival outcome in patients with early stage breast cancer   UBC discovery may lead to ‘smart’ therapies for breast, ovarian cancer   Elderly breast cancer patients receive chemotherapy if treated in private practices   Black women in Chicago more likely to die from breast cancer than white women   Breast MRIs delay cancer treatment by weeks -study   Breast cancer survivors struggle with cognitive problems several years after treatment   Genetic factors implicated in survival gap for breast, ovarian or prostate cancer   Breast cancer risk with HRT may be small   Does working nights cause breast cancer?   Causes of Bone Loss in Breast Cancer Survivors Identified

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]